- 11:24 PM Student visa applications to US, UK see 25% drop
- 10:46 PM Astec LifeSciences to start a project in Q3FY11
- 10:20 PM Rangebound session for Nifty ahead of Nov series e...
- 09:30 PM Politics stirs over Ayodhya mosque report
- 09:23 PM Clean energy, better homes cut pollution, save liv...
- 09:11 PM US to face stimulus aftershocks: Warren Buffett
- 09:02 PM Expert stock/sector picks for tricky markets
- 08:53 PM Indian techie logging out of downturn gloom
- 08:52 PM Expert stock/sector picks in these markets
- 08:44 PM Govt not to relook at arrested CLB member's probe



Pharma analysts tell Moneycontrol that cut in excise duty, a liberal new drug policy in April, drugs worth USD 25 billion coming off patent in 2006 and a USD 27 billion CRAMS market by 2010 will augur well for both domestic and MNC pharma companies.
Analysts think that these companies in the pharma sector can give returns of anywhere between 15-30% this year on a conservative estimate.
Ranbaxy, which was recently hammered on the bourses, could be a good value pick at around Rs 300 with a possible one-year price target of Rs 400, says Avdesh Garg of Pranav securities. While pharma MNCs like Aventis, Merck, Pfizer, GSK Pharma, and Wyeth Laboratories will reap benefits of strong product pipeline, domestic pharma stocks like Ranbaxy, Dr Reddy’s, Glenmark Pharma, Sun Pharma and Biocon will benefit from budgetary sops on their R&D efforts.
The major story for 2006, however, is likely to emerge in the nascent contract research and manufacturing services – popularly known as CRAMS. Dishman Pharmaceuticals, Nicholas Piramal, Shasun Chemicals and Jubilant Organosys are some of the heavyweights well equipped to take advantage of a booming CRAMS industry.
Continued on page 2
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- Ex-bonus, RIL will see correction: SP Tulsian

- Mkts to remain strong; bet on midcaps: Ramesh Damani
- Sudarshan Sukhani's top five picks for today's trade

- Nifty to test 5500 post 5-7% correction: JM Financial

- Ganeshaspeaks: Market prediction for Nov 25
- Expert sector picks to power your portfolio ahead

- Below Rs 94, Mahindra Satyam can test Rs 85: Bhambwani

- Mah Satyam looks at out-of-court settlement with creditors

- S&P raises fears over health of some banks
Source: ft.com
- Auto sector growth to push up demand for rubber
Source: Business Line
- High networth individuals see glitter in commodities
Source: Business Line
- Tatas may launch electric Indica by early 2011
Source: Business Line










